UK-US Agree Zero Tariff Deal on Medicines
The UK and US have agreed a three-year deal to maintain 0% tariffs on pharmaceuticals, aiming to boost trade and secure NHS access to new treatments. Read the full details.
The UK and US have agreed a three-year deal to maintain 0% tariffs on pharmaceuticals, aiming to boost trade and secure NHS access to new treatments. Read the full details.
The UK and US have finalised a landmark trade agreement to eliminate tariffs on pharmaceutical products. Discover how this deal aims to lower drug costs and boost medical innovation.
The UK and US have agreed a three-year deal to maintain 0% import tariffs on pharmaceuticals, aiming to secure NHS access to cutting-edge treatments and boost investment. Read the full details.
The UK is poised to strike a deal with the US removing tariffs on pharmaceuticals, following warnings of investment cuts. The agreement hinges on the NHS paying more for American medicines. Read the full details.
Canada's PM announces a £285m support package for steel and lumber industries crippled by US tariffs. Discover the new quotas and freight subsidies.
Explosive revelations emerge about Donald Trump's private stance on revolutionary weight loss drugs while new research highlights their massive economic potential.
Former President Donald Trump's proposed 25% tariff on EU pasta imports could significantly increase food costs for British consumers and disrupt supply chains.
US health authorities sound alarm after toxic chemical discovery in Chinese-manufactured cough syrups distributed across multiple states, prompting urgent product recalls.
British luxury car manufacturer Aston Martin faces significant financial headwinds from Trump-era tariffs and supply chain issues, prompting profit warnings and strategic reviews.
Traditional Sinterklaas celebrations in Rhinebeck and beyond could be cancelled as Dutch organisers struggle with soaring costs from Trump's aluminium and steel tariffs, putting festive traditions at risk.
Donald Trump's proposed 25% tariffs on Canadian goods echo Ronald Reagan's 1980s trade war, risking economic damage and diplomatic fallout between the historic allies.
Former President Donald Trump threatens to reignite trade tensions with a 25% tariff on Canadian steel, risking collateral damage to UK manufacturing and global supply chains.
Former TV doctor and Senate candidate Mehmet Oz under fire after resurfaced video reveals his support for Trump administration's drug pricing policies that critics say favoured pharmaceutical giants.
A comprehensive safety review of a widely prescribed antidepressant has uncovered significant cardiovascular concerns and substantial weight gain among users, raising urgent questions about prescription practices.
Groundbreaking research reveals ibuprofen's potential cancer-prevention properties, challenging everything we thought we knew about this everyday medication.
German agricultural machinery manufacturer Krone suspends all US exports, blaming complex 'hidden tariffs' that make American market unprofitable despite strong demand.
Italian pasta producers face devastating 25% tariffs under Trump's new trade war, threatening centuries-old family businesses and the future of authentic Italian pasta exports to the US market.
Former President Donald Trump's proposal to make other nations pay 'full price' for US pharmaceuticals could dramatically increase drug costs for the NHS, potentially forcing British taxpayers to foot a multi-billion pound bill.
Exclusive: The NHS could pay up to 25% more for vital medicines under a proposed voluntary scheme aimed at resolving long-standing tensions with pharmaceutical companies and preventing potential supply disruptions.
Former President Donald Trump's controversial proposal to impose universal 10% tariffs on all imports could trigger the largest tax increase in modern history, raising serious concerns among economists and trade experts.
Groundbreaking research reveals a widely prescribed pain medication used by millions in Britain could increase the risk of developing blood cancers. Experts urge caution.
Exclusive investigation reveals Donald Trump's radical plans to overhaul pharmaceutical pricing, with potential seismic implications for Britain's National Health Service and prescription charges.
Medical authorities sound alarm about unapproved use of leucovorin for autism treatment after prominent doctor's claims about 'miracle pill' results. Exclusive investigation reveals growing concerns among healthcare professionals.
Major US lawsuits linking Tylenol (paracetamol) to autism in children raise serious questions for UK parents and health officials. Learn about the scientific claims and legal battles.
Top US CEOs issue stark warnings as Donald Trump proposes sweeping 10% universal tariffs, threatening a new global trade war and price hikes for consumers.
Pfizer announces a surprising turnaround in its weight-loss strategy, advancing two new daily pills in a heated battle for the lucrative obesity drug market dominated by injectables.
Former President Donald Trump's proposed 10% tariff on all imports could send the price of Halloween costumes, decorations, and candy soaring, industry leaders warn, threatening a chilling effect on the annual celebration.
A landmark US court ruling has struck down Donald Trump's signature tariffs on foreign steel and aluminium, declaring them an unconstitutional overreach of presidential power. The decision sends shockwaves through global markets and UK trade policy.
A groundbreaking pill from Retro Biosciences promises to reverse brain aging and combat dementia. Early human trials show potential to revolutionise Alzheimer's treatment. Discover the science behind this medical marvel.
Plans to slash US steel tariffs have been abruptly shelved ahead of Donald Trump's UK visit, in a major diplomatic move to avoid a political row. The decision, seen as a concession to the former President, raises questions about UK trade policy independen